PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2028330
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2028330
Non-Invasive Prenatal Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of non-invasive prenatal testing Market
The global non-invasive prenatal testing market was valued at USD 8.42 billion in 2025 and increased to USD 9.92 billion in 2026, with projections reaching USD 36.79 billion by 2034. The market is experiencing rapid expansion due to increasing awareness of prenatal screening and advancements in genetic testing technologies. North America dominated the market with a 51.62% share in 2025, supported by strong healthcare infrastructure and high adoption of advanced diagnostic solutions.
Non-invasive prenatal testing (NIPT) is used to detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome by analyzing cell-free fetal DNA in maternal blood. The growing need for early and accurate detection of genetic disorders is driving the adoption of these tests globally.
Market Trends
A significant trend in the market is the shift from invasive to non-invasive prenatal testing methods. Non-invasive tests offer higher safety, accuracy, and reduced risk compared to traditional invasive procedures, leading to increased adoption among healthcare providers and patients.
Additionally, continuous technological advancements in genomic sequencing, particularly next-generation sequencing (NGS), are improving test accuracy and efficiency. Companies are expanding their product portfolios and investing in research to develop more advanced and cost-effective testing solutions.
Driving Factors
The rising prevalence of chromosomal abnormalities and genetic disorders is a key factor driving market growth. Increasing maternal age and changing lifestyle factors have contributed to higher risks of genetic conditions in newborns, increasing the demand for early screening.
Furthermore, the growing adoption of advanced diagnostic technologies and favorable reimbursement policies in developed regions are supporting market expansion. Increasing awareness among expectant parents regarding the benefits of early detection is also contributing to market growth.
Restraining Factors
The market faces challenges due to the high cost of non-invasive prenatal tests, which limits accessibility in developing regions. The lack of awareness and limited healthcare infrastructure in certain areas further restrict market penetration.
Additionally, variations in reimbursement policies across regions and concerns regarding test affordability may hinder widespread adoption.
Segmentation Analysis
By product, the consumables and reagents segment dominates the market, driven by the increasing number of tests conducted globally and continuous product innovations. The instruments segment is also growing due to advancements in diagnostic equipment.
By technology, the next-generation sequencing (NGS) segment holds the largest share, supported by its high accuracy and widespread use in detecting chromosomal abnormalities. Other technologies such as PCR and microarray also contribute to market growth.
By end-user, clinical laboratories lead the market, as they are equipped with advanced technologies and handle a large volume of diagnostic tests. Hospitals also play a significant role in supporting prenatal screening services.
Regional Analysis
North America leads the market with a value of USD 4.35 billion in 2025, driven by high adoption rates, strong presence of key players, and increasing prevalence of genetic disorders. The United States plays a major role in regional dominance due to continuous innovation and investment in diagnostic technologies.
Europe is experiencing significant growth due to supportive reimbursement policies and integration of NIPT into public healthcare systems. Asia Pacific is the fastest-growing region, supported by improving healthcare infrastructure, rising awareness, and a large patient population in countries such as China and India. Latin America and the Middle East & Africa are also witnessing gradual growth due to increasing awareness and adoption of non-invasive testing methods.
Key Industry Players and Developments
Leading companies such as Illumina, Natera, LabCorp, F. Hoffmann-La Roche, and Eurofins LifeCodexx are focusing on expanding their product portfolios and strengthening their global presence. These companies are investing in research and development to introduce innovative and accurate testing solutions.
Recent developments include product launches, strategic collaborations, and acquisitions aimed at enhancing technological capabilities and expanding market reach. Increasing investments in precision diagnostics are further driving innovation in the market.
Conclusion
The non-invasive prenatal testing market is projected to grow from USD 8.42 billion in 2025 to USD 36.79 billion by 2034, driven by increasing demand for early detection of genetic disorders and advancements in diagnostic technologies. While high costs and limited accessibility pose challenges, continuous innovation, rising awareness, and supportive healthcare policies will sustain strong market growth in the coming years.
Segmentation By Product, Technology, End User, and Region
By Product * Consumables & Reagents
- Instruments
By Technology
Next Generation Sequencing (NGS)
- Microarray
- Polymerase Chain Reaction (PCR)
- Rolling Circular Amplification
By End User * Hospitals
- Clinical Laboratories
By Region * North America (By Product, By Technology, By End User, and By Country)
- U.S. (By Product)
- Canada (By Product)
- Europe (By Product, By Technology, By End User, and By Country)
- U.K. (By Product)
- Germany (By Product)
- France (By Product)
- Italy (By Product)
- Spain (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, By Technology, By End User, and By Country)
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Product, By Technology, By End User, and By Country)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, By Technology, By End User, and By Country)
- GCC (By Product)
- South Africa (By Product)
- Rest of Middle East & Africa (By Product)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Technological Advancements in Non-invasive Prenatal Testing (NIPT) Techniques
- 4.2. Number of NIPT Tests Performed, Key Players/ Region, 2021/2025
- 4.3. Key Industry Developments - Mergers, Acquisitions, Etc.
- 4.4. Impact of COVID-19 on Non-invasive Prenatal Testing Market
5. Global Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Consumables & Reagents
- 5.1.2. Instruments
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Next Generation Sequencing (NGS)
- 5.2.2. Microarray
- 5.2.3. Polymerase Chain Reaction (PCR)
- 5.2.4. Rolling Circular Amplification
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Hospitals
- 5.3.2. Diagnostic Laboratories
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Consumables & Reagents
- 6.1.2. Instruments
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Next Generation Sequencing (NGS)
- 6.2.2. Microarray
- 6.2.3. Polymerase Chain Reaction (PCR)
- 6.2.4. Rolling Circular Amplification
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Hospitals
- 6.3.2. Diagnostic Laboratories
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Product
- 6.4.2. Canada
- 6.4.2.1. By Product
- 6.4.1. U.S.
7. Europe Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Consumables & Reagents
- 7.1.2. Instruments
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Next Generation Sequencing (NGS)
- 7.2.2. Microarray
- 7.2.3. Polymerase Chain Reaction (PCR)
- 7.2.4. Rolling Circular Amplification
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Hospitals
- 7.3.2. Diagnostic Laboratories
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Product
- 7.4.2. Germany
- 7.4.2.1. By Product
- 7.4.3. France
- 7.4.3.1. By Product
- 7.4.4. Spain
- 7.4.4.1. By Product
- 7.4.5. Italy
- 7.4.5.1. By Product
- 7.4.6. Scandinavia
- 7.4.6.1. By Product
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product
- 7.4.1. U.K.
8. Asia pacific Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Consumables & Reagents
- 8.1.2. Instruments
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Next Generation Sequencing (NGS)
- 8.2.2. Microarray
- 8.2.3. Polymerase Chain Reaction (PCR)
- 8.2.4. Rolling Circular Amplification
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Laboratories
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Product
- 8.4.2. China
- 8.4.2.1. By Product
- 8.4.3. India
- 8.4.3.1. By Product
- 8.4.4. Australia
- 8.4.4.1. By Product
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product
- 8.4.1. Japan
9. Latin America Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Consumables & Reagents
- 9.1.2. Instruments
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Next Generation Sequencing (NGS)
- 9.2.2. Microarray
- 9.2.3. Polymerase Chain Reaction (PCR)
- 9.2.4. Rolling Circular Amplification
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Hospitals
- 9.3.2. Diagnostic Laboratories
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product
- 9.4.2. Mexico
- 9.4.2.1. By Product
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product
- 9.4.1. Brazil
10. Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Consumables & Reagents
- 10.1.2. Instruments
- 10.2. Market Analysis, Insights and Forecast - By Technology
- 10.2.1. Next Generation Sequencing (NGS)
- 10.2.2. Microarray
- 10.2.3. Polymerase Chain Reaction (PCR)
- 10.2.4. Rolling Circular Amplification
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Hospitals
- 10.3.2. Diagnostic Laboratories
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. GCC Countries
- 10.4.1.1. By Product
- 10.4.2. South Africa
- 10.4.2.1. By Product
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Product
- 10.4.1. GCC Countries
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Illumina, Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. YOURGENE HEALTH
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Natera
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. F. Hoffmann-La Roche Ltd
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. PerkinElmer Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Laboratory Corporation of America
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Eurofins LifeCodexx GmbH
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Other Players
- 11.2.1. Illumina, Inc.
List of Tables
- Table 1: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 2: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 3: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 4: Global Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 5: North America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 6: U.S Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 7: Canada Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 8: North America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 9: North America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 10: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 11: Germany Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 12: U.K Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 13: France Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 14: Italy Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 15: Spain Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 16: Scandinavia Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 17: Rest of Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 18: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 19: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 20: Europe Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 22: Japan Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 23: China Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 24: India Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 25: Australia Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 26: South East Asia Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 27: Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 28: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 29: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 30: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 31: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 32: Brazil Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 33: Mexico Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 34: Rest of Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 35: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 36: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 37: Latin America Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 38: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 39: GCC Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 40: South Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 41: Rest of Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 42: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 43: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 44: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Non-invasive Prenatal Testing (NIPT) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Instruments, 2025-2034
- Figure 4: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Consumables & Reagents, 2025-2034
- Figure 5: Global Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025 & 2034
- Figure 6: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by PCR, 2025-2034
- Figure 7: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Microarray, 2025-2034
- Figure 8: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by NGS, 2025-2034
- Figure 9: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Roller Circular Amplification, 2025-2034
- Figure 10: Global Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025 & 2034
- Figure 11: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Hospitals, 2025-2034
- Figure 12: Global Non-invasive Prenatal Testing (NIPT) Market Forecast (USD billion), by Clinical Laboratories, 2025-2034
- Figure 13: Global Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Region, 2025 & 2034
- Figure 14: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
- Figure 15: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
- Figure 16: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
- Figure 17: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
- Figure 18: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
- Figure 20: North America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country, 2025 & 2034
- Figure 21: North America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country, 2025
- Figure 22: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
- Figure 23: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
- Figure 24: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
- Figure 25: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
- Figure 26: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
- Figure 28: Europe Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Europe Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
- Figure 31: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
- Figure 32: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
- Figure 33: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
- Figure 34: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
- Figure 36: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
- Figure 39: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
- Figure 40: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
- Figure 41: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
- Figure 42: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
- Figure 44: Latin America Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Latin America Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Product, 2025 & 2034
- Figure 47: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Product, 2025
- Figure 48: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by Technology, 2025 & 2034
- Figure 49: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by Technology, 2025
- Figure 50: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), by End-user, 2025 & 2034
- Figure 51: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), by End-user, 2025
- Figure 52: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 53: Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 54: Global Non-invasive Prenatal Testing (NIPT) Market Share (%), By Company, 2025
